Alibaba Health Upgrades China's First Hepatitis B Integrated Care Plan with Full-Cycle, Broad-Coverage Services and Increased Coverage up to RMB 3 Million

728With World Hepatitis Day approaching, the prevention and treatment of liver diseases have once again becomeFocusAlibaba HealthJuly 26announced on the 10th,Previously“Medical Care + Pharmaceuticals + Insurance” Integrated Million-Coverage Medical Insuranceon the basis of risk,Coverage for Individuals Focused on Liver Protection and HealthPreventionEarly Screening, ConsultationTreatment、Medication ManagementInsuranceCompensatedFull-cycle services,Upgrade its chronic disease coverage plan。

Data from the "2020 China Health and Health Statistical Yearbook" show that China is a global hotspot for liver cancer, with 80% of cases associated with hepatitis B. Meanwhile, unhealthy lifestyle habits such as staying up late, alcohol consumption, and poor diet are leading to a noticeable trend toward younger age groups in liver disease incidence. How to protect and maintain liver health has become a topic of widespread social concern.

Alibaba Health has been committed to leveraging internet technology to advance the prevention and control of liver diseases. On June 11, Alibaba Health, in partnership with ZhongAn Insurance, Huirui Gene, and Chia Tai Tianqing, jointly launched China’s first million-yuan medical insurance service integrating “medical care, pharmaceuticals, and insurance” specifically for hepatitis B patients (abbreviated as “Hepatitis B Insurance”). This initiative truly enables hepatitis B patients and their families to access medications more easily, reduce treatment costs, and enjoy comprehensive coverage. The product launch has attracted widespread attention from various sectors.

On this basis, on July 26, the “Hepatitis B Protection” plan officially launched an upgraded version: if the insured is unfortunately diagnosed with liver cancer, in addition to the original coverage limit of RMB 1 million, a new option with a coverage limit of RMB 3 million is now available for users to choose.

This means that, one month later, Alibaba Health once again takes the industry lead, redefining “liver protection and care” through its efforts characterized by “full-cycle coverage, broad reach, and a strong emphasis on innovation.”

Effective immediately, hepatitis B patients with medication and insurance needs can search for “Hao Yao Bao” on the Taobao app, navigate to the “Hepatitis B Insurance” service page, and select suitable insurance products according to their needs.

Meanwhile, Alibaba Health is also continuing to deepen its presence in the field of liver disease, launching more products and services in specialized segments of liver care, including:

● On July 26, “Ai Gan Bao” (Liver Care Insurance) was launched, targeting sub-healthy individuals with risk factors for liver disease due to chronic late-night habits and alcohol consumption. For as low as RMB 9.9 per month, users can enjoy comprehensive coverage of up to RMB 3 million annually, along with discounted medication purchases and related professional services.

● On July 26, a special feature page for Hepatitis Day was launched. Users can access it by searching “Hepatitis Day” in the Yilu App. In addition to providing an entry point for the “Hepatitis B Protection” product, the special page offers a range of resources including live broadcasts on liver disease prevention and control, popular science education on liver health, liver disease testing and screening, free clinical consultations for liver conditions, hepatitis B vaccination inquiry services, and recommended medications for liver diseases. This comprehensive platform covers the full spectrum of products and services needed for liver protection and care.

● In the realm of hepatitis B prevention, Alibaba Health has also introduced innovative internet-based solutions. To address user demand for hepatitis vaccination, Alibaba Health, in partnership with Kangtai Biological Products, has launched a hepatitis B vaccine inoculation inquiry service. Users can view nearby hepatitis B vaccination sites and related information on the platform, enabling them to complete online vaccine appointments without leaving home.

● Alibaba Health will also partner with Hangzhou Zhilan Health Co., Ltd. to launch the “Little Shell Happy Maternal and Infant Protection Plan,” dedicated to safeguarding infants from hepatitis B virus infection through precise management of mother-to-child transmission prevention protocols.

“From authoritative health education and professional screening, diagnosis, and treatment, to reliable medications and tailored insurance coverage, we continuously raise the bar for industry services. This is not only where AliHealth’s capabilities lie, but also where our responsibilities rest,” said Chen Bo, Vice President of AliHealth. “We are committed to leveraging technological innovation to provide end-to-end professional health management services for many chronic diseases, including liver disease, thereby becoming a trusted expert in safeguarding the health of more people.”